Workplace cluster of Bell’s palsy in Lima, Peru by Erik J Reaves et al.
Reaves et al. BMC Research Notes 2014, 7:289
http://www.biomedcentral.com/1756-0500/7/289SHORT REPORT Open AccessWorkplace cluster of Bell’s palsy in Lima, Peru
Erik J Reaves1*, Mariana Ramos1 and Daniel G Bausch1,2Abstract
Background: We report on a workplace cluster of Bell’s palsy that occurred within a four-month period in 2011
among employees of a three-story office building in Lima, Peru and our investigation to determine the etiology
and associated risk factors.
Findings: An outbreak investigation was conducted to identify possible common infectious or environmental
exposures and included patient interviews, reviews of medical records, an epidemiologic survey, serological analysis
for IgM and IgG antibodies to putative Bell’s palsy-inducing pathogens, and an environmental exposure assessment
of the office building. Three cases of Bell’s palsy were reported among 65 at-risk employees, attack rate 4.6%.
Although two patients had underlying risk factors, there was no clear association or common identifiable risk
factor among all cases. Serologic analysis showed no evidence of recent infections, and air and water sample
measures of all known chemical or neurotoxins were below maximum allowable concentrations for exposure.
Conclusions: An infection spread among workplace employees could not be excluded as a potential cause of this
cluster; however, it was unlikely a pathogen commonly associated with individual cases of Bell’s palsy. Although
a specific etiology was not identified among all cases, we believe this methodology will aid future outbreak
investigations of Bell’s palsy and a better understanding of its etiology. While environmental assessments may be
useful in their ability to ascertain the cause of clusters of Bell’s palsy, future investigations should prioritize focus
on common infectious etiology.
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Introduction
Bell’s palsy, an acute facial paralysis affecting the 7th cra-
nial nerve, comprises up to half of all peripheral facial
palsies. Paralysis is typically unilateral. The incidence in
the general population ranges from 15-30 cases per
100,000 person-years and is roughly equal among men
and women [1]. Peak incidence occurs in the fifth dec-
ade of life and the syndrome is more common in pa-
tients with diabetes and in pregnant women [2]. There
have been reports of increased incidence in cooler, win-
ter months, although precise relationships with climate
and season remain to be elucidated [3,4]. Other condi-
tions known to produce facial nerve palsy include struc-
tural lesions of the ear or parotid gland, Guillain-Barré
syndrome, Ramsay Hunt syndrome, otitis media, sarcoid-
osis, and influenza vaccination, although these conditions* Correspondence: erikreaves@gmail.com
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palsy [2].
The cause of Bell’s palsy is unknown. Infectious eti-
ologies have been hypothesized, including infection
or reactivation of neurotropic herpes viruses, namely
herpes simplex virus type 1 (HSV-1) and varicella-
zoster virus (VZV), HIV/AIDS, and Lyme disease (Borrelia
burgdorferi), resulting in peripheral neuropathy [5-7].
Antecedent respiratory infections have also been postu-
lated to be a cause [8]. Although an analysis using the Vac-
cine Adverse Event Reporting System in the U.S. found an
increase of Bell’s palsy cases in the 3-month period follow-
ing parenteral inactivated influenza vaccination [9], no
evidence of increased risk was found in a subsequent
self-controlled case-series study using the General Prac-
tice Research Database [10]. Bell’s palsy associated with
hypothyroidism has also been reported [11].
Up to 85 percent of patients with Bell’s palsy recover
spontaneously without treatment [12]. For patients who
present within 72 hours of onset of symptoms, a taper-
ing, short-course of oral corticosteroids to reduce facialLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Reaves et al. BMC Research Notes 2014, 7:289 Page 2 of 5
http://www.biomedcentral.com/1756-0500/7/289nerve inflammation has been shown to increase the re-
turn of facial function [2,13]. Treatment with acyclovir
or valacyclovir aimed at possible HSV-1 infection is of
uncertain benefit.
Rarely, temporal or geographic clusters of Bell’s palsy
have been reported, suggesting a possible common in-
fectious or toxic exposure, although a definitive etiology
has yet to be identified [4,8,14]. We report on a small
workplace cluster of cases of Bell’s palsy in urban Lima,
Peru, and our investigation to attempt to identify a cause
and characterize risk factors among workplace employees.
The outbreak and investigation
Between April 20th and August 23rd, 2011, three cases of
Bell’s palsy were reported among 65 employees (attack
rate 4.6%) at a three-story office work place in Lima,
Peru. Support was requested from administrative staff
that occupied the office building in Lima on September
1st, 2011. In response, we conducted an investigation to
confirm the existence of an outbreak, identify risk fac-
tors, and explore possible infectious and environmental
etiologies. Activities of the outbreak investigation team
included patient interviews, reviews of medical records,
an epidemiologic survey of workplace employees, and la-
boratory analysis for infections that could predispose to
Bell’s palsy. Survey responses and serum samples were
obtained by voluntary consent and all names and survey
and test results were kept strictly confidential. In addition,
an environmental exposure assessment was arranged by
the work place administration.
The majority of the employees at the work site are
Peruvian. All three patients worked in the same office
building but at different workstations. Patients 1 and 3
worked on different floors while Patient 2 worked pri-
marily outside on the building’s exterior grounds. None
of the patients lived together or reported common expo-
sures outside the work place. By their self-report, the pa-
tients were casual work place acquaintances but did not
have particularly close contact or interactions either dur-
ing or after work hours. The patients were medically
evaluated and treated by their primary healthcare practi-
tioner. The clinical features were consistent with what
has been previously described for Bell’s palsy [1]. Clinical
and demographic characteristics of each case are pre-
sented in Table 1.
To evaluate for possible infectious etiologies, serum
samples were tested by enzyme-linked immunosorbent
assay and compliment fixation for IgM and IgG antibodies
to Coxsackie B, cytomegalovirus, Epstein-Barr virus,
HSV-1, influenza A and B, paramyxovirus, and varicella
zoster viruses, Mycoplasma pneumoniae, and Haemophilus
influenzae. Two serum samples were obtained from each
patient, on September 1st and October 25th, 2011, which
was 4-8 months after the onset of symptoms for the threepatients. Only Patient 3 still had facial paralysis at the time
of testing and of our investigation. Testing was performed
at a private laboratory in Lima using commercially avail-
able kits (Diagnostic Automation, Inc.; Quest Diagnostics;
Roche Cobas; Vircell).
All three patients had IgG antibody titers indicative of
previous exposure or vaccination to all the tested patho-
gens, with the exception of Patient 3, who was IgG nega-
tive for HSV-1. All IgM tests were negative. Although
ticks carrying B. burgdorferi variants have been reported
in some areas of South America with rare reports of as-
sociated human Lyme disease, no cases have ever been
reported in Peru and therefore testing for Lyme disease
was not readily available or conducted [15]. We were
not able to test the patients for HIV infection, but the
prevalence of HIV/AIDS in Peru is low (<1%) and none
of the patients are in the identified high-risk age group
(25-34 years) for HIV infection in the country or re-
ported risk factors for newly acquired HIV infection
(Peru Ministry of Health and USAID statistics).
To evaluate for a possible common environmental ex-
posure, a building air and water quality assessment was
performed by a contracted, commercial industrial hy-
giene consult service with expertise in indoor pollution.
The building had a shared, re-circulated air-handling
system between its three floors. The ventilation system
and work centers were inspected to measure for known
chemical and neurotoxins to detect possible sources of
bioaerosoles and hazardous airborne contaminants. Point
sources for potable water were sampled and levels of vari-
ous metals, bacteria, and volatile organic compounds were
measured. Samples were collected and analyzed according
to guidelines established by the National Institute of
Occupational Safety and Health (NIOSH). All environmen-
tal samples measured below the maximum allowable level
set by local and NIOSH standards.
This study was approved by the U.S. Naval Medical
Research Unit No. 6 Institutional Review Board in com-
pliance with all applicable U.S. Federal regulations gov-
erning the protection human subjects. Survey responses
and serology samples were voluntary and analyzed de-
identified. The three patients with Bell’s palsy provided
written consent for the investigators of this outbreak to
publish non-personal identifiable information related to
the clinical aspects of their conditions.
Discussion
We investigated the hypotheses that the cause of this
cluster was either infectious or a shared environmental
exposure in the workplace. From our review of the lit-
erature, this is the fourth reported cluster of cases of
Bell’s palsy [4,8,14]. As with the other three reports, we
were unable to identify a specific etiology for the cases
collectively or individually. Although we were not able
Table 1 Characteristics of three patients with Bell’s palsy
Characteristic Patient 1 Patient 2 Patient 3
Date of Onset 04/20/2011 06/14/2011 08/23/2011
Age 48 46 60
Gender Female Male Female
Nationality Peruvian Peruvian Peruvian
Affected Side Right Left Right
Severity Mild Mild Moderate
Duration 4 weeks 4 weeks 5 weeks
Medical Treatment Ac, B, S, PT Ac, NSAIDs, PT NSAIDs, S, V
Resolution Complete Complete Complete
Recurrence No No No
Prior contact with person with BP No No No
Past Medical History Recurrent otitis media (last episode
February 2 months prior to BP),
Adult chickenpox in 2000
Childhood chickenpox URI 2 months prior to BP, Hypothyroidism,
Non-insulin-dependent diabetes mellitus,
Childhood chickenpox
Routine Medications None None levothyroxine, metformin, isotretinoin,
flutamide, calcium, MVI
Preceding Vaccinations None None Influenza vaccine 05/31/2011
Tobacco use No No No
Preceding Travel Southeastern U.S. 7 months prior to BP None Western Europe one week prior to BP
Abbreviations: Ac acyclovir, B vitamin B complex, BP Bell’s Palsy, NSAIDs non-steroidal anti-inflammatory drugs, S oral corticosteroids, V valacyclovir, PT physiotherapy,
URI Upper respiratory illness.
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of Bell’s palsy, the broadly positive IgG serological results
of the three patients with Bell’s palsy are no doubt typ-
ical of the general population, since almost everyone is
exposed at some point to these common pathogens. Fur-
thermore, the negative IgM serology results suggest that
no recent infection with these pathogens occurred, al-
though the IgM response in reinfection or reactivation
may be blunted [16].
HSV-1 has been suggested as a possible nonepidemic
cause because of elevated antibody titers in patients af-
fected with Bell’s palsy; however, viral DNA is inconsist-
ently isolated during acute infection and has been
present in healthy study controls [6]. In this analysis,
Patient 3 did not have IgM or IgG antibody titers to
HSV-1, excluding primary infection or reactivation as a
cause of this cluster and further questioning its role in
the pathogenesis of clinical Bell’s palsy. VZV reactivation
without rash i.e. zoster sine herpete may have been the
etiology given the previous history of varicella infection
in each patient; however, whether this occurred by
chance or constituted some common predisposing path-
way remains unclear. In addition, since blood samples
for laboratory testing were taken months after symptom
onset, and after resolution of symptoms in two of the
three patients, we cannot completely exclude that acute
infection with one of the tested pathogens occurred, ei-
ther in the absence of detectable antibody response orwith subsequent reversion of IgM titer back to negative
before serum collection for testing occurred.
Although we were unable to test for Lyme disease, we
believe it is an unlikely explanation for these cases.
While Patient 1 traveled to the southeastern United States
where Lyme disease endemicity is highest, the travel oc-
curred 7 months prior to disease onset. Patient 3 had re-
cently traveled to an area where Lyme disease is endemic,
and during the typical season of transmission, but did not
report significant outdoor activities or exposure to ticks
during the trip and had no symptoms consistent with
B. burgdorferi infection, such as erythema migrans or
arthritis. Although we do not consider HIV infection
as a likely etiology of these cases, it cannot be completely
excluded since we were unable to arrange testing for this
virus.
There was no obvious environmental toxic etiology of
the cases. Although the air in Lima is among the most
polluted in Latin America, surpassing the international
standard established by the American Agency of Envir-
onmental Protection by 122.1 percent (Peru National
Statistics and Information Institute, 2006), the air and
water quality assessment did not reveal exposure risks
inside the building. If observed cases of Bell’s palsy re-
sulted from an environmental exposure, there likely
would have been other individuals with clinical or sub-
clinical evidence of paralysis; however, no other office
staff had signs or symptoms of facial nerve dysfunction
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the workplace. Furthermore, Bell’s palsy is not recog-
nized as an outcome of neurotoxic chemical exposure,
nor are cranial nerves often affected by such exposures
[14]. Concentrations of measured contaminants in air
and water quality samples were all below detection or
applicable exposure standards and did not reveal a pat-
tern consistent with disease risk. Nonetheless, subclinical
facial nerve dysfunction that could be present with chem-
ical neurotoxin exposure may have occurred among clinic-
ally healthy employees but was not evident in our
investigation. Investigations of possible toxins in two other
outbreaks of Bell’s palsy also failed to reveal any obvious
environmental cause [8,14].
A number of possible predisposing conditions, includ-
ing diabetes and hypothyroidism, and triggering events,
including recent (ie. with ~2 months) influenza vaccin-
ation and otitis media and upper respiratory infection of
unknown etiologies, were noted for the three patients.
However, these conditions and events were not uniform
across all three cases, and thus cannot be invoked as
common factors for the cluster, although they may be
implicated for an individual case. It should be noted that
all of these conditions and events are also common in
the general population in Lima.
In the absence of a shared cause for Bell’s palsy, it is
possible that the clustering of these three cases occurred
by chance, although this would seem unlikely when we
consider that, according to the records and memory of
people at the work place, no case of Bell’s palsy had ever
been reported there before experiencing an attack rate
of 4.6% (4,615 per 100,000 person-years) over a four-
month period in 2011. By comparison, in the district
where the office building is located and the Bell’s palsy
cluster occurred, with an estimated population of 85,284
from the 2011 census, the Peru Ministry of Health re-
corded five cases of Bell’s palsy in 2010 and four in 2011,
excluding the cases reported here. This corresponds to
attack rates of less than 0.0059%. Bell’s palsy is not a
reportable disease in Peru so these numbers may be
under-estimates. Interestingly, the cluster in Lima oc-
curred during the fall and winter months, consistent
with previous observations of increased incidence in
winter months in the southern hemisphere [4].
Conclusions
Although we were unable to identify a specific etiology
for this outbreak of Bell’s palsy, we believe that it is
nevertheless important that these “negative data” appear
in the scientific literature to aid in the investigation of
possible future cases and clusters, hopefully eventually
leading to identification of a specific etiology and ultim-
ately control and prevention measures. We believe that
the causes of Bell’s palsy are probably multifactorial,involving infectious, environmental, and/or emotional
triggers super-imposed on persons predisposed through
underlying microvascular or neurologic impairment due to
chronic conditions such as diabetes mellitus.
To our knowledge only two other investigations of
an outbreak of Bell’s palsy included an assessment to
characterize the role of environmental exposures as a
possible etiology [8,14]. While serving an important public
health purpose to belay concerns of fearful employees, our
investigation results further support the conclusion that
there is limited additional benefit in conducting an envir-
onmental exposure assessment to ascertain causality in
outbreaks of Bell’s palsy. Future investigations might in-
stead focus on common infectious etiology.
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